Adelphi Capital LLP Takeda Pharmaceutical CO LTD Transaction History

Adelphi Capital LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 22, 2021	SELL	$16.71 - $19.9 $127 Million - $151 Million	-7,584,930 Closed	0 $0
Q4 2020 Jan 25, 2021	SELL	$15.39 - $18.97 $10.6 Million - $13.1 Million	-689,297 Reduced 8.33%	7,584,930 $138 Million
Q3 2020 Oct 29, 2020	SELL	$17.1 - $19.19 $15.1 Million - $16.9 Million	-882,088 Reduced 9.63%	8,274,227 $148 Million
Q2 2020 Jul 24, 2020	SELL	$14.59 - $19.5 $1.84 Million - $2.46 Million	-126,228 Reduced 1.36%	9,156,315 $164 Million
Q1 2020 Apr 14, 2020	BUY	$13.02 - $20.31 $4.22 Million - $6.58 Million	323,759 Added 3.61%	9,282,543 $141 Million
Q4 2019 Jan 22, 2020	SELL	$16.88 - $20.83 $548,701 - $677,099	-32,506 Reduced 0.36%	8,958,784 $177 Million
Q3 2019 Oct 28, 2019	BUY	$16.15 - $17.99 $17.1 Million - $19.1 Million	1,060,174 Added 13.37%	8,991,290 $155 Million
Q2 2019 Jul 30, 2019	SELL	$16.58 - $20.49 $22.2 Million - $27.4 Million	-1,339,419 Reduced 14.45%	7,931,116 $140 Million
Q1 2019 May 07, 2019	BUY	$16.7 - $21.52 $155 Million - $200 Million	9,270,535 New	9,270,535 $189 Million

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Adelphi Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Adelphi Capital LLP with notifications on news.